Qube Research & Technologies (QRT)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-122,174
| Closed | -$28.1K | – | 3232 |
|
|
2024
Q4 | $28.1K | Buy |
122,174
+44,458
| +57% | +$10.2K | ﹤0.01% | 2419 |
|
|
2024
Q3 | $167K | Buy |
77,716
+49,557
| +176% | +$107K | ﹤0.01% | 2203 |
|
|
2024
Q2 | $145K | Sell |
28,159
-109,722
| -80% | -$566K | ﹤0.01% | 2167 |
|
|
2024
Q1 | $738K | Buy |
+137,881
| New | +$738K | ﹤0.01% | 1984 |
|
|
2022
Q3 | – | Sell |
-5,357
| Closed | -$52K | – | 3099 |
|
|
2022
Q2 | $52K | Buy |
+5,357
| New | +$52K | ﹤0.01% | 2105 |
|
|
2021
Q3 | – | Sell |
-7,877
| Closed | -$429K | – | 2880 |
|
|
2021
Q2 | $429K | Buy |
7,877
+4,228
| +116% | +$230K | ﹤0.01% | 1350 |
|
|
2021
Q1 | $273K | Buy |
+3,649
| New | +$273K | ﹤0.01% | 1504 |
|